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Objective: Radiotherapy is an important therapeutic method for lung cancer. However, in clinical situations, cellular
resistance to radiotherapy is a significant component of tumor treatment failure. Thus, clarification in cellular
mechanism underlying radiosensitivity of cancer cell is urgently needed. In this study, we established a radiation
model of Lewis lung carcinoma in C57BL/6 mice and investigated the possible signaling molecule involved in this
process.
Methods: C57BL/6 mice were subcutaneously transplanted with Lewis lung carcinoma cells and locally irradiated
followed by measurement in tumor volume. Levels of miR-545 and Ku70 mRNA expression were determined by
using Quantitative Real-Time PCR. Expression of Ku70 was determined by using western blot assay. Cell viability was
analyzed by MTT assay. Cell apoptosis was examined by using TUNEL assay.
Results: In mice bearing Lewis lung carcinoma tumor, local radiotherapy suppressed tumor growth as well as
enhanced expression of miR-545 and downregulated Ku70 level. Inhibition of miR-545 expression reduced
radiosensitivity of Lewis tumor. In vitro Lewis lung carcinoma cells experiment, we observed that miR-545
regulated Ku70 expression by targeting Ku70 3′UTR and this process was involved in radiotherapy. This was
demonstrated by result of cell proliferation assay in which irradiation reduced apoptosis of cells was mediated
by miR-545 inactivation which was reversed by Ku70 silence.
Conclusion: miR-545 increased radiosensitivity of Lewis lung carcinoma via inhibiting Ku70 expression.
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Lung cancer continues to be one of the most prevalent
malignancies worldwide and is the leading cause of
death in both men and women. There is around 20 % of
new cancer cases worldwide were diagnosed in China
each year; however, more people die from lung cancer
than from any other kind of cancer. Importantly, for
conveniently be located, approximately 90 % of patients
with lung cancer receive external beam radiation
treatment as one component of their treatment. How-
ever, what is important for radiotherapy is cellular
desensitization. Accumulated evidence pointed out that
combination of radiation and radiosensitivity-related* Correspondence: MeiHong_MH@163.com
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and harmlessness of radiotherapy [1, 2]. Thus, explor-
ing the explicit cellular mechanisms of radiotherapy is
important.
Ku70 protein, cooperating with Ku80 and DNA-
dependent protein kinase (DNA-PK) catalytic subunit
(DNA-PKcs), is involved in DNA double-strand break
(DNA DSB) repair and V(D)J recombination that is es-
sential for DNA repair, chromosome maintenance, tran-
scription regulation. Recent studies have revealed that
Ku70 may be a susceptibility factor for radiation-related
cancers. For example, inhibition of Ku70 can increase
the radiosensitivity of 786-O cells by enhancing apop-
tosis [3]. Antisense Ku70 using the antisense nucleic acid
strategy increased radiosensitivity of human squamous
cell lung carcinoma cell line [4]. Thus, Ku70 might actle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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with lung cancer [5]. Although there is evidence on
increasing ionizing radiosensitivity by Ku70-deficiency in
lung cancer, the mechanism regulation on Ku70 expres-
sion during radiotherapy is not yet clear.
Previously, expression of Ku70 was regulated by
microRNA in brain. MicroRNAs (miRNAs), a class of
small noncoding RNAs with approximately 22 nucleo-
tides in length [6, 7] can suppress posttranscriptional
gene expression by binding to the 3′-untranslated re-
gions (3′-UTRs) of mRNAs, which induces translational
inhibition or target mRNA degradation [8]. miRNAs has
been showed to be involved in proliferation [9], differenti-
ation [10], and apoptosis [11] of lung cancer cells, which
is linked to tumor formation and progression. Although, it
was reported that miRNAs are involved in many signaling
pathways and DNA damage repair processes, affecting cel-
lular radiosensitivity [1], to our knowledge, no research has
focus on the role of miR-545 in irradiating lung cancer.
Previously, miR-545 has been reported to suppress cell
proliferation by targeting cyclin D1 and CDK4 in lung can-
cer cells [12]. Thus, we hypothesized that miR-545 may be
involved in the process of radiotherapy in lung cancer.
In this study, we established a radiation model of
Lewis lung carcinoma in C57BL/6 mice and aimed to
evaluate the role of miR-545 in irradiating tumor. We
also directly assessed whether Ku70 was involved in this
process and aimed to identify the regulating relationship
between miR-545 and Ku70 in the radiotherapy.
Material and methods
Mice, cell lines and reagents
Animal experimental protocols were performed in 8–12-
week-old female C57BL/6 mice, which obtained from the
Institute of Laboratory Animal Science (Chinese academy
sciences, Shanghai) and were bred and maintained under
specific pathogen-free conditions. All experiment proto-
cols were approved by Medical Experimental Animal
Center of Southeast University.
Lewis lung carcinoma cell line was purchased from
ATCC (USA) and cultured in RPMI 1640 medium contain-
ing 10 % fetal bovine serum. After grew against the wall of
flask, formed a monolayer, the cells were digested by 0.25 %
trypsin to prepare cell suspensions at 1 × 106/ml.
RPMI 1640 medium and fetal bovine serum were
purchased from Gibco (Invitrogen Company, USA).
Lipofectamine 2000 transfection reagent was obtained
from Invitrogen Life Technologies (Grand Island, NY,
USA). Anti-Ku70 antibody was obtained from Santa
Cruz Biotechnology Inc. (Santa Cruz, CA, USA).
Tumor xenograft and irradiation therapy
For tumor transplantation, lewis lung carcinoma cells
were transfected with or without miR-545 inhibitor andthen suspended in 100 μL PBS and mixed with 20 %
matrigel. Tumors were generated by prepared 2 × 106
cells/ml cells subcutaneously injected into the abdomen
of C57BL/6 mice. Seven days after the cell inoculated,
the mice were divided into two group including control
group and radiotherapy group. For radiotherapy, tumors
inoculation sites were received a single fraction of
12 Gy/1f/1d. In brief, mice in control group and radi-
ation therapy group were anesthetized by intraperitoneal
injection with 10 % chloral hydrate (350 mg/kg). The
four limbs were fixed with medical proof fabric. The
body surface of tumor location was marked by marker
pen and compensated with 1 cm petrolatum gauze. X-ray
form 6MV-X (Elekta Limited, West Sussex, UK) vertically
irradiated target area under condition of 100 cm Source-
skin distance and 12Gy/1f/1d. The irradiated vision is
2.0 cm × 2.0 cm. Notably, mice were kept waking state
during radiotherapy. During therapy, the tumor volume
was measured using calipers as length ×width × depth per
two days. Sixteen days after inoculation, animals were
euthanized and tumors were removed for Quantitative
Real-Time PCR or western blot assay.
Cell treatment with miRNA inhibitor or mimics
Lewis lung carcinoma cells were treated with miR-545
mimic or miR-545 inhibitor (Ambion Pre-miR miRNA
Precursors, Life Technologies) using Oligofectamine (Life
Technologies) according to the manufacturer’s instruc-
tions. Both miRNA mimics negative control (mimic-NC)
and miRNA inhibitor negative control (inhibitor-NC) were
severed as negative controls in the experiments respect-
ively. Further analysis of the samples (infection or RNA
isolation) was performed at 48 h post-transfection. Lewis
lung cancer cells were irradiated after 6 h when pretreated
with miR-545-mimics, miR-545-inhibitors, or their nega-









Lewis lung carcinoma cells were seeded at a density of
1400 cells/well. On the next day, cells were irradiated
with dose 5 Gy for 24 h. After that, 50 mL of 5 mg/mL
3-(4,5-Dimethylthiazol-2-yl) 22,5-diphenyltetrazolium
bromide (MTT) was added to wells for 4 h, and then
the media were replaced with DMSO for analysis of op-
tical density using a mQuant Microplate Spectrophotom-
eter (BioTek, UK) at a wavelength of 540 nm.
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Total RNA was extracted from the Lewis lung carcin-
oma cells with the Trizol Reagent (Invitrogen, Carlsbad,
CA, USA). The mature miR-545 and Ku70 mRNA were
quantified by using Quantitative Real-Time PCR (qRT-
PCR) assays with fluorescent nucleic acid dye. Each sam-
ple (1 μg) was reverse-transcribed into cDNA by using
the RealMasterMix First Strand cDNA Synthesis Kit
(Tiangen). Real-time PCR was conducted by using SYBR
Premix ExTagTM (Takara) according to the manufac-
turer’s protocols and performed in the Applied Biosys-
tems 7500 Real-time PCR system. The threshold cycle
(CT) is defined as the fractional cycle number at which
the fluorescence passes the fixed threshold. The miRNA
expression levels were normalized to U6 RNA and the
Ku70 mRNA levels were normalized to actin mRNA. All
reactions were run in triplicate.
Bioinformatics analysis of miR-545 target in Ku70
Based on bioinformatics analysis, we predicted that
hsa-miR-545 can bind with the 3′UTR region of Ku70
by using four common websites (Target Scan: http://
www.targetscan.org/, miRanda: http://www.microrna.org/,
Microcosm: http://www.ebi.ac.uk/enright-srv/microcosm/
cgi-bin/targets/v5/search.pl, and PITA: http://genie.
weizmann.ac.il/) (Fig. 3a).
Plasmid construction and luciferase reporter assays
For Ku70 3′UTR reporter assay, Lewis lung carcinoma
cells were placed in 24-well plates (1 × 105 cells per well)
and then cotransfected with the pGL3 Luciferase Reporter
Vectors (Promega, WI, USA) according to manufactures’
protocol. The mimics and inhibitors of hsa-miR-545 and
their negative controls (RIBO Bio, Guangzhou, P.R. China)
were cotransfected with the reporter plasmids at a final
concentration of 100 nmol/μl. 48 h after transfection in
Lewis lung cancer cells, luciferase activity in lysates was
measured with a Dual-Luciferase Reporter Assay System
(Promega, WI, USA) followed by the manufacture’s sugges-
tions and normalized against the activity of the pRL-SV40.
Independent triplicate experiments were performed for
each plasmid construct.
TUNEL staining
The TUNEL reaction which based on labeling of DNA
strand breaks was conducted to detect cells apoptosis
and performed with an in situ cell detection kit (Roche
Applied Science, Indianapolis, IN, USA), according to
the manufacturer’s instruction. In brief, sections in 2
changes of xylene for 5 min each, and hydrate with 2
changes of 100 % ethanol for 3 min each, and 95 % etha-
nol for 1 min followed by rinsing in distilled water. After
pretreated with proteinase K, cells were cultured in TdT
Reaction Buffer for 10 min and then conducted TdTReaction in TdT Reaction Mixture for 1–2 h at 37–40 °C
in humidified chamber. The reaction was stopped with
washing buffer and the sample was resuspended in PBS
containing FITC-Avidin D for 30 min at room
temperature. The reaction mixture was counterstained
with PI or DAPI for 20 min. TUNEL-positive nuclei
(stained brown) were counted by Motic Images Advanced
3.2 in 10 random fields (×200), and then averaged.
Western blot
Proteins in Cells were extracted by inM-PER mammalian
protein extraction reagent (Pierce Biotechnology) followed
by centrifugation at 15 000 g for 10 min. Protein concen-
tration of cell lysates was measured by using DC protein
assay kit (Bio-Rad). Proteins (10–20 mg) were separated
by 10 % SDS-polyacrylamide gel electrophoresis and
transferred to PVDF membrane from Bio-Rad (Hercules,
CA, USA). Two hours after blocking in 5 % nonfat milk,
the protein blots were then incubated with primary anti-
bodies in 3 % bovine serum albumin at 4 °C overnight,
followed by incubation with secondary antibodies at room
temperature for 2 h. The protein signals were detected by
ECL method.
Ku70 interference
Lewis lung carcinoma cells were treated with Ku70
siRNA or scrambled siRNA as negative control accord-
ing to the manufacturer’s instructions. Briefly, siRNA
and OligofectAmine were mixed separately with Opti-
Mem and incubated for 15 min at room temperature.
And then, these reagents were combined and incubated
for 15 min before adding to the cells in RPMI 1640 with-
out penicillin and streptomycin. Notably, Ku70 siRNA
was cotransfected with miR-545 inhibitor. Twenty-four
hours after transfection, the cells were irradiated with a
single dose of 5 Gy/1f/1d for 24 h. And then the cell via-
bility and apoptosis were examined accordingly.
Statistical analysis
All statistical analyses were performed using SPSS 16.0
software (Chicago, IL). Student’s t test was used to
analyze the significance between two groups. Error bars
represent SD. P-Values < 0.05 were considered statisti-
cally significant.
Results
Local radiotherapy suppressed tumor growth in mice
bearing Lewis lung carcinoma tumor
After subcutaneous transplantation, C57BL/6 mice bear-
ing Lewis lung carcinoma tumors were locally irradiated
with a single dose of 12 Gy for 7 days, which resulted in
a significant reduction in tumor growth (Fig. 1a). Upon
to qRT-PCR analysis on expression of miR-545 and
Ku70 in radiation therapy tumor, the results showed an
Fig. 1 Effect of local high-dose irradiation on tumor growth and expression of miR-545 and Ku70 in mice bearing Lewis lung carcinoma tumor.
Seven days after C57BL/6 mice transfected with Lewis lung cancer cell lines, tumors were irradiated with a single dose of 12 Gy/1f/1d, whereas
control mice received no radiotherapy. (a) Growth of tumor in irradiated mice. (b) Expressions of miR-545 and (c) Ku70 were determined by using
Quantitative Real-Time PCR in tumors. The results were represented as mean ± SD. *P < 0.05 compared with control
F3
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level mRNA compared with untreated tumors (Fig. 1c).
Suppression of miR-545 expression reduced radiosensitivity
of tumor in mice bearing Lewis lung carcinoma tumor
To determine the effect of miR-545 on the modulation
of radiotherapy of tumors, Lewis lung carcinoma cells
were transfected with miR-545 inhibitor before subcuta-
neous transplantation in C57BL/6 mice. After locally ir-
radiated with a single dose of 12 Gy/1f/1d, the tumors
volume was much bigger than that of untreated tumors
during irradiation (Fig. 2a). Additionally, compared with
negative control, knock down of miR-545 expression up-
regulated Ku70 expression in tumor (Fig. 2b).
Regulated Ku70 expression by miR-545 in Ku70 3′UTR
Ku70 was regarded as a potential target gene of miR-545
using TargetScan Release 5.2 in which we found a bind-
ing site for miR-545 in the 3′UTR of Ku70 mRNA
(Fig. 3a). To confirm the key regulated role of miR-545 in
Ku70 expression in tumors, Lewis lung carcinoma cells
were transfected with miR-545 mimic to overexpression
miR-545 which was shown in Fig. 3b. The entire 3′UTRof Ku70 was inserted downstream of the luciferase gene
and assayed in Lewis lung carcinoma cells and the result
showed a decrease (45 %) in luciferase activity (Fig. 3c).
Upon to expression of Ku70, transfected miR-545 mimic
downregulated both Ku70 mRNA (Fig. 3d) and Ku70
protein expression (Fig. 3e). Additionally, Lewis lung car-
cinoma cells were transfected with miR-545 inhibitor to
silence miR-545 expression which was shown in Fig. 3f.
The data of luciferase reporter gene assay showed that
knock down miR-545 leaded to increase of Ku70 tran-
scriptional activity (Fig. 3g). In the case of expression of
Ku70, transfected with miR-545 inhibitor upregulated
both Ku70 mRNA level (Fig. 3h) and Ku70 expression
(Fig. 3i).
Regulated Ku70 expression by miR-545 in irradiated-Lewis
lung carcinoma cells
As indicated in Fig. 3, miR-545 exerted negative impact
on expression of Ku70 in Lewis lung carcinoma cells. To
ascertain this regulational process occurred during
radiotherapy, Lewis lung carcinoma cells were irradiated
with a single dose of 5 Gy/1f/1d. Consequently, irradi-
ation increased expression of miR-545 (Fig. 4a), but
Fig. 2 Effect of silenced miR-545 on radiosensitivity of tumor and Ku70 miRNA expression. Before injected into C57BL/6 mice, the Lewis lung
cancer cells were transfected with miR-545 inhibitor. Tumors were irradiated with a single dose of 12 Gy/1f/1d as in Fig. 1. (a) Growth of tumor in
irradiated mice. (b) Expression of Ku70 was determined by using quantity RT-PCR in tumors. The results were represented as mean ± SD. *P < 0.05
compared with negative control
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mRNA (Fig. 4b) and Ku70 protein (Fig. 4c). Further-
more, miR-545 was silenced by cells being trans-
fected with miR-545 inhibitor. Reversely, expression
of Ku70 inhibited by irradiation was upregulated in
levels of Ku70 mRNA (Fig. 4d) and Ku70 protein
(Fig. 4e).
Interaction between miR-545 and Ku70 in
irradiation-induced cells apoptosis
The above results indicated that the regulation of Ku70
expression by miR-545 is involved in the process of
radiotherapy of Lewis lung cancer. Next, we tried to
detect whether this process affects Lewis lung cancer
cells proliferation. As shown in Fig. 5a, cell viability was
reduced by irradiation and was increased by cell pre-
transfected with miR-545 inhibitor. However, this in-
crease was reversed by cells cotransfected with si-Ku70
and miR-545 inhibitor suggesting the essential signaling
of inhibition of Ku70 expression by miR-545 in radio-
therapy. Furthermore, regulated Ku70 expression by
miR-545 was also involved in irradiation-induced apop-
tosis of Lewis lung carcinoma cells (Fig. 5b).
Discussion
Reduction of radiation susceptibility commonly resulted
in failure of cancer therapy. Thus much attention has
been focused on the identification the detailed mechan-
ism underlying radiotherapy to obtain the possible ther-
apy target. In the present study, we established X ray
irradiated in vitro rat model of xenografted lung tumor
and in vivo Lewis lung Carcinoma cells. In results, we
observed that radiotherapy enhanced miR-545 expres-
sion while inhibited Ku70 expression in both irradiated
xenografted tumor and cells. Moreover, our data also
showed that upregulated miR-545 suppressed Ku70transcriptional activity by targeting its 3′UTR, which
plays a vital role in radiotherapeutic sensitivity.
It is well accepted that miRNAs were the key regulator
for various cellular functions [13]. Accumulated evi-
dence pointed out that miRNAs are also involved in
many signaling pathways and DNA damage repair pro-
cesses, which is essential for cancer radiotherapy [1]. In
this present research, we confirmed and are the first to
note that the miR-545 was upregulated during irradi-
ation of Lewis lung carcinoma tumor in vivo and
in vitro. Based to its inhibition effect on proliferation of
lung cancer cell [12], overpression of miR-545 was
assumed to exert resistance impact on tumor growth
during radiotherapy, which was supported by tumor
growth inhibition in vivo and Lewis cell apoptosis
in vitro in our research. Notably, inhibition of miR-545
desensitized radiation of tumor. Given this, miR-545
might be a therapy site for high irradiation efficiency.
In consideration of high human lung cancer causes
many deaths worldwide, elucidation on the molecular
mechanism underlying the radioresistance lung cancer
cells is particularly important. DNA double-strand breaks
(DSBs) caused by ionizing radiation leads to different kind
of DNA damages that can result in tumor growth inhib-
ition in cancer cells [14]. The nonhomologous end joining
(NHEJ) pathway, however, is regarded as the major path-
way for the repair of radiation induced DSBs in mamma-
lian cells [15, 16]. One of the main participants in this
pathway is the DNA-dependent protein kinase (DNA-PK)
that consists of a large catalytic subunit, DNA-PKcs,
and a heterodimeric protein named Ku, which is a
highly stable protein complex consisting of Ku70 and
Ku80 subunits [17, 18]. Ku is the initiated protein for
DSBs repair and it recognizes DSBs and recruits add-
itional pathway components to process and repair the
damage. In this study, Ku70 founction as an indicator
Fig. 3 Targeting site of miR-545 in the Ku70 3′UTR. a Ku70 3′UTR was predicted a binding site for hsa-miR-545 and mRNA sequence is shown with
potential binding sites indicated in white. The highly conserved mature miR-545 sequence in mammals and potential binding between the
miR-545 seed region to the mouse Ku70 3′UTR sequence are shown. 24 h after transfected with miR-454 mimic, Lewis lung carcinoma cells were
lyzed to examine (b) miR-454 expression by using quantity RT-PCR, (c) Ku70 3′UTR activity using luciferase report, (d) Ku 70 mRNA level by using
quantity RT-PCR and (e) Ku 70 protein expression by using western blot assay. 24 h after transfected with miR-454 inhibitor, Lewis lung cancer
cells were lyzed to examine (f) miR-454 level, (g) Ku70 3′UTR activity, (h) Ku 70 mRNA level and (i) Ku 70 protein expression by using the same
detection as before. The results were represented as mean ± SD. *P < 0.05 compared with negative control
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expression was regulated by miRNA in brain [12],
there is no evidence on regulation of its synthesis by
miR-545 in lung cancer. We confirmed the possible
targeting region of Ku70 mRNA by miR-545 in 3′UTR by
using bioinformatics analysis. Moreover, it was supportedby that inhibition of miR-545 increased Ku70 3′UTR activ-
ity and Ku70 protein expression.
In conclusion, we established Lewis Lung Carcinoma
bearing mice in C57BL/6 mice. The findings suggest that
miR-545 plays an important role in the mechanism
underlying the radioresistance of Lewis Lung Carcinoma
Fig. 4 Effect of high-dose irradiation on expression of miR-545 and Ku70 in Lewis lung cancer cells. 24 h after irradiated with a single dose of
5 Gy/1f/1d, cells were lyzed to detect expression of miR-545 (a) and Ku70 mRNA by using quantity RT-PCR (b) and Ku protein by western blot (c).
The cells were transfected with miR-545 inhibitor and then exposed to radiation followed by detection on expression of Ku70 mRNA (d) and
Ku70 protein (e). The results were represented as mean ± SD. *P < 0.05 compared with corresponding control
Fig. 5 Effect of irradiation on cell proliferation. The cells were transfected with miR-545 inhibitor or si-Ku70 and then irradiated with a single dose
of 5 Gy/1f/1d for 24 h. (a) cell viability by using MTT assay. (b) Cell apoptosis by using TUNEL assay
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lecular mechanism underlying the radioresistance of the
Lewis Lung Carcinoma cell lines indicated that over-
expressed miR545 inhibited Ku70 activity. These found-
ing will contribute to a better understanding of not only
the molecular mechanisms of radiotherapy in lung epi-
thelial cells, but also the development of combination
between new gene therapies and radiotherapies for types
of malignancies.
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